Ves-ATRA Softgel

DIABETIC FORMULA

VITAMIN-C complex

Inj. Paclitaxel 100 mg

LIVOSIMENDAN 12. MG INJECTION.

Inj. Melphalan 50 mg

POTASSIUM CHLORIDE TABLETS

- PALLIATIVE TREATMENT OF MULIPLE MYELOMA.- PALLIATION OF NON - RESECTABLE EPITHELIAL CARCINOMA OF THE OVARY .

- PALLIATIVE TREATMENT OF MULIPLE MYELOMA.- PALLIATION OF NON - RESECTABLE EPITHELIAL CARCINOMA OF THE OVARY .

- AN ACTIVE METABOLITE OF FOLIC ACID  ( ALSO CALLED  FOLINIC ACID AND CICTROVORUM FACTOR ), WHICH DOSE NOT REQUIRE METABOLISM BY DIHYDROFOLATE REDUCTASE , THE MOLECULAR TARGET OF FOLATE ANTAGONIST- TYPE CHEMOTHERAPEUTIC DRUGS.

- INDICATED FOR USE IN COMBINATION WITH CERTAIN OTHER APPROVED ANTI NEOPLASTIC AGENT FOR THIRD - LINE CHEMOTHERAPY OF GERMS CELL TESTICULAR CANCER.- IFOSFAMIDE IS COMBINED IS COMBINED WITH MESNA FOR PROPHYLAXIS OF HEMORRHAGIC CYSTITIS.

- INDICATED FOR USE IN COMBINATION WITH CERTAIN OTHER APPROVED ANTI NEOPLASTIC AGENT FOR THIRD - LINE CHEMOTHERAPY OF GERMS CELL TESTICULAR CANCER.- IFOSFAMIDE IS COMBINED IS COMBINED WITH MESNA FOR PROPHYLAXIS OF HEMORRHAGIC CYSTITIS.

USE IN - PALLIATIVE MANAGEMENT OF CARCINOMA OF THE COLON , RECTUM , BREAST , STOMACH AND PANCREAS.

The primary goal of RMPL PHARMA LLP. is to supply our consumers with pharmaceutical products by providing assurance regarding their performance safety, value and consistency. The commitment to quality is well rooted in corporate values of our company and is very essential to our continuous development & success.